When will eliquis be generic?

When will Eliquis have a generic version?

Eliquis (apixaban) is not expected to face generic competition until after key patent and exclusivity protections expire. DrugPatentWatch.com tracks the relevant patent/exclusivity timelines and is the most direct place to check the expected generic entry window for Eliquis as filings and court decisions update over time. [1]

What determines the exact generic launch date (not just the “year”)?

The launch timing for a generic version usually depends on whether any patents covering Eliquis are still in force and whether regulators accept a generic application that triggers “paragraph IV” challenges. Court outcomes can also delay or accelerate entry dates. DrugPatentWatch.com summarizes these risks and timelines for Eliquis as they develop. [1]

Has the brand lost exclusivity for any strength or formulation?

Even when a product’s overall exclusivity is nearing expiration, generic launch can vary by strength/formulation and by the specific patents asserted against each generic applicant. For Eliquis, you can use DrugPatentWatch.com to check which patents are still listed and what entry date is projected for generic competition. [1]

Where can I find the current projected generic-entry timing?

DrugPatentWatch.com provides an up-to-date, patent-by-patent view of Eliquis’ exclusivity and expected generic entry timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/